99.51%
REPORTED PURITY
COA
SAMPLE REPORT
CANADA
DISPATCH
RETATRUTIDE
20MG · LYOPHILIZED
Retatrutide is a triple receptor agonist (GLP-1, GIP, glucagon) investigated in laboratory metabolic-research settings.
A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.
Use code WELCOME15 for 15% OFF at checkout
Save more with box purchases. Add 9 more to unlock 50% off this vial.
Wholesale pricing available for schools, clinics, and repeat customers. Request a quote →
RECONSTITUTION & PROTOCOL
Full Guide Provided After Purchase
A complete reconstitution and protocol guide is included in the box with every order — printed for clean bench-side reference.
- PURITY
- ≥99.3%
- CAS NUMBER
- 2381089-83-2
- APPEARANCE
- Lyophilized white powder
- SHELF LIFE
- 24 months unopened. 60 days reconstituted (refrigerated).
- STORAGE
- Store at 2–8°C, protected from light. Long-term: -20°C.
- RECONSTITUTION
- Reconstitute with bacteriostatic water (0.9% benzyl alcohol). Full protocol included in the box.
QUALITY VERIFIED
PREMIUM PACKAGING
DISCREET SHIPPING
SECURE CHECKOUT
Encrypted payments & private order details
RESEARCH-GRADE QUALITY
≥99% HPLC purity across the catalog
THIRD-PARTY TESTED
Independently verified by Janoshik Analytical
DISCREET SHIPPING
Sealed, unbranded, tracked worldwide
GLOBAL FULFILLMENT NETWORK
Global Fulfillment Network
Fast, secure, and discreet fulfillment through our Canada and Philippines distribution network.
RESEARCH FOCUS
Explore RETATRUTIDE
Retatrutide is a triple receptor agonist (GLP-1, GIP, glucagon) investigated in laboratory metabolic-research settings.
A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.
For laboratory investigation only. Research findings do not establish safety or effectiveness for personal use. Not for human or animal consumption.
COMPOUND
RETATRUTIDE
VIAL SIZE
20MG
WHY FIRSTLABS PH
Not all peptides are equal.
WHAT YOU GET
FIRSTLABS
TYPICAL
Published third-party lab reports
—
Listed purity: ≥99.3%
—
Ships from Canada
—
Clear research-only labeling
—
Real people answering your questions
—
Open documentation
Published laboratory reports are available to review before ordering. Confirm the compound, vial size and batch with FirstLabs.
Discreet fulfillment
Canada and Philippines fulfillment options, with shipping details available before you complete checkout.
Clear research labeling
Compound identity, vial size and handling information are listed for laboratory purchasers. These are not medicines for personal use.
LAB EVIDENCE
Read the report. Check the batch.
Documentation matters more than a badge.
A report verifies only the sample described—not every vial size or shipment. Confirm which documentation applies to your order. Analysis and reported dates are not manufacture or expiry dates.
Retatrutide 20mg · 99.51%
Freedom Diagnostics · Jun 9, 2026 (reported)
Lot / batch: R2055
View exact COA- Match the compound name and vial size.
- Check the batch identifier, test date and laboratory.
- Read identity, content and purity results together.
- A purity result alone does not establish sterility or safety for use.
STORAGE & HANDLING
Details for your laboratory.
- Storage
- Store at 2–8°C, protected from light. Long-term: -20°C.
- Appearance
- Lyophilized white powder
- Shelf life
- 24 months unopened. 60 days reconstituted (refrigerated).
- Listed CAS number
- 2381089-83-2
Follow the applicable batch documentation and your laboratory’s procedures. FirstLabs products are not supplied for personal dosing or treatment.
CUSTOMER REVIEWS
What researchers say
Loading reviews…
QUESTIONS
Frequently Asked About RETATRUTIDE
· YOU MAY ALSO LIKE ·
Related research compounds
METABOLIC RESEARCHRETATRUTIDE
10MG
A triple receptor agonist of GLP-1, GIP, and glucagon investigated in laboratory metabolic-research models. Research interest includes appetite-pathway studies, energy-balance research, hepatic lipid-metabolism research, and incretin-signaling investigations. For laboratory research use only.
METABOLIC RESEARCHOUT OF STOCKTIRZEPATIDE
10MG
A dual GIP and GLP-1 receptor agonist used as a reference compound in laboratory metabolic research. Research interest includes incretin-pathway studies, energy-balance research, glycemic-marker research models, and gastric-motility research. For laboratory research use only.
METABOLIC RESEARCHELORALINTIDE
10MG
A next-generation, receptor-selective amylin agonist designed to deliver the appetite suppression and weight-loss benefits of Cagrilintide while reducing nausea and other GI side effects through more targeted receptor activation. Research interest includes early-satiety signaling, powerful appetite suppression, lean mass preservation (in animal studies), minimal CTR activation for reduced GI side effects, and potential combination research with Tirzepatide (studies ongoing). For laboratory research use only.
METABOLIC RESEARCHAOD-9604
5MG
A modified fragment of human growth hormone (hGH 176-191). Research interest includes lipolysis-pathway studies, lipid-metabolism research models, and cartilage research. For laboratory research use only.